☰

Chang-il Hwang - Publications

Affiliations: 
2012-2018 Microbiology and Molecular Genetics University of California, Davis, Davis, CA 
Tree Info Similar researchers PubMed Report error

33 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Xu J, Roe JS, Lee E, Tonelli C, Ji KY, Younis OW, Somervile TDD, Yao M, Milazzo JP, Tiriac H, Kolarzyk AM, Lee E, Grem JL, Lazenby AJ, Grunkemeyer JA, ... ... Hwang CI, et al. Engrailed-1 Promotes Pancreatic Cancer Metastasis. Advanced Science (Weinheim, Baden-Wurttemberg, Germany). e2308537. PMID 38110836 DOI: 10.1002/advs.202308537  0.559
2023 Lee E, Archasappawat S, Ji K, Pena J, Fernandez-Vega V, Gangaraju R, Beesabathuni NS, Kim MJ, Tian Q, Shah PS, Scampavia L, Spicer TP, Hwang CI. A new vulnerability to BET inhibition due to enhanced autophagy in BRCA2 deficient pancreatic cancer. Cell Death & Disease. 14: 620. PMID 37735513 DOI: 10.1038/s41419-023-06145-9  0.426
2023 Mouti MA, Deng S, Pook M, Malzahn J, Rendek A, Militi S, Nibhani R, Soonawalla Z, Oppermann U, Hwang CI, Pauklin S. KMT2A associates with PHF5A-PHF14-HMG20A-RAI1 subcomplex in pancreatic cancer stem cells and epigenetically regulates their characteristics. Nature Communications. 14: 5685. PMID 37709746 DOI: 10.1038/s41467-023-41297-4  0.381
2023 Lee E, Archasappawat S, Ji K, Pena J, Fernandez-Vega V, Gangaraju R, Beesabathuni NS, Kim MJ, Tian Q, Shah P, Scampavia L, Spicer T, Hwang CI. A new vulnerability to BET inhibition due to enhanced autophagy in BRCA2 deficient pancreatic cancer. Biorxiv : the Preprint Server For Biology. PMID 37398312 DOI: 10.1101/2023.05.30.542934  0.433
2022 Usman OH, Zhang L, Xie G, Kocher HM, Hwang CI, Wang YJ, Mallory X, Irianto J. Genomic heterogeneity in pancreatic cancer organoids and its stability with culture. Npj Genomic Medicine. 7: 71. PMID 36535941 DOI: 10.1038/s41525-022-00342-9  0.321
2022 Casolino R, Corbo V, Beer P, Hwang CI, Paiella S, Silvestri V, Ottini L, Biankin AV. Germline Aberrations in Pancreatic Cancer: Implications for Clinical Care. Cancers. 14. PMID 35805011 DOI: 10.3390/cancers14133239  0.338
2022 Zhang D, Lindstrom A, Kim EJ, Hwang CI, Hall ML, Lin TY, Li Y. SEMA3C Supports Pancreatic Cancer Progression by Regulating the Autophagy Process and Tumor Immune Microenvironment. Frontiers in Oncology. 12: 890154. PMID 35785187 DOI: 10.3389/fonc.2022.890154  0.487
2021 Wang SS, Xu J, Ji KY, Hwang CI. Epigenetic Alterations in Pancreatic Cancer Metastasis. Biomolecules. 11. PMID 34439749 DOI: 10.3390/biom11081082  0.385
2021 Kim HR, Yim J, Yoo HB, Lee SE, Oh S, Jung S, Hwang CI, Shin DM, Kim T, Yoo KH, Kim YS, Lee HW, Roe JS. EVI1 activates tumor-promoting transcriptional enhancers in pancreatic cancer. Nar Cancer. 3: zcab023. PMID 34316710 DOI: 10.1093/narcan/zcab023  0.358
2021 Nielsen SR, Strøbech JE, Horton ER, Jackstadt R, Laitala A, Bravo MC, Maltese G, Jensen ARD, Reuten R, Rafaeva M, Karim SA, Hwang CI, Arnes L, Tuveson DA, Sansom OJ, et al. Suppression of tumor-associated neutrophils by lorlatinib attenuates pancreatic cancer growth and improves treatment with immune checkpoint blockade. Nature Communications. 12: 3414. PMID 34099731 DOI: 10.1038/s41467-021-23731-7  0.571
2020 Miyabayashi K, Baker LA, Deschenes A, Traub B, Caligiuri G, Plenker D, Alagesan B, Belleau P, Li S, Kendall J, Jang GH, Kawaguchi RK, Somerville TDD, Tiriac H, Hwang CI, et al. Intraductal transplantation models of human pancreatic ductal adenocarcinoma reveal progressive transition of molecular subtypes. Cancer Discovery. PMID 32703770 DOI: 10.1158/2159-8290.Cd-20-0133  0.621
2020 Oni TE, Biffi G, Baker LA, Hao Y, Tonelli C, Somerville TDD, Deschênes A, Belleau P, Hwang CI, Sánchez-Rivera FJ, Cox H, Brosnan E, Doshi A, Lumia RP, Khaledi K, et al. SOAT1 promotes mevalonate pathway dependency in pancreatic cancer. The Journal of Experimental Medicine. 217. PMID 32633781 DOI: 10.1084/Jem.20192389  0.683
2019 Ponz-Sarvise M, Corbo V, Tiriac H, Engle DD, Frese KK, Oni TE, Hwang CI, Öhlund D, Chio IIC, Baker LA, Filippini D, Wright K, Bapiro TE, Huang PS, Smith PD, et al. Identification of Resistance Pathways Specific to Malignancy Using Organoid Models of Pancreatic Cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 31492749 DOI: 10.1158/1078-0432.Ccr-19-1398  0.612
2019 Hwang C, Roe J, Lee EJ, Tonelli C, Somervile TDD, Yao M, Milazzo JP, Tiriac H, Park Y, Vakoc C, Tuveson D. Abstract B25: Engrailed-1 promotes pancreatic cancer progression via antagonizing COMPASS activity Cancer Research. 79. DOI: 10.1158/1538-7445.Panca19-B25  0.663
2017 Roe JS, Hwang CI, Somerville TDD, Milazzo JP, Lee EJ, Da Silva B, Maiorino L, Tiriac H, Young CM, Miyabayashi K, Filippini D, Creighton B, Burkhart RA, Buscaglia JM, Kim EJ, et al. Enhancer Reprogramming Promotes Pancreatic Cancer Metastasis. Cell. PMID 28757253 DOI: 10.1016/J.Cell.2017.07.007  0.58
2017 Öhlund D, Handly-Santana A, Biffi G, Elyada E, Almeida AS, Ponz-Sarvise M, Corbo V, Oni TE, Hearn SA, Lee EJ, Chio II, Hwang CI, Tiriac H, Baker LA, Engle DD, et al. Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer. The Journal of Experimental Medicine. PMID 28232471 DOI: 10.1084/Jem.20162024  0.71
2017 Tucci ST, Kakwere H, Kheirolomoom A, Seo JW, Ingham E, Hwang C, Ferrara K. Abstract 3108: Gemcitabine nanoparticles showin vitroefficacy in murine pancreatic ductal adenocarcinoma Cancer Research. 77: 3108-3108. DOI: 10.1158/1538-7445.Am2017-3108  0.375
2016 Boj SF, Hwang CI, Baker LA, Engle DD, Tuveson DA, Clevers H. Model organoids provide new research opportunities for ductal pancreatic cancer. Molecular & Cellular Oncology. 3: e1014757. PMID 27308531 DOI: 10.1080/23723556.2015.1014757  0.648
2016 Zaaroor M, Sinai A, Goldsher D, Eran A, Nassar M, Schlesinger I, Parker J, Ravikumar V, Ghanouni P, Stein S, Halpern C, Krishna V, Hargrove A, Agrawal P, Changizi B, ... ... Hwang C, et al. 5th International Symposium on Focused Ultrasound Journal of Therapeutic Ultrasound. 4. DOI: 10.1186/S40349-016-0076-5  0.427
2016 Baker LA, Tiriac H, Corbo V, Boj SF, Hwang C, Chio IIC, Engle DD, Jager M, Ponz-Sarvise M, Spector MS, Gracanin A, Oni T, Yu KH, Boxtel Rv, Huch M, et al. Abstract B16: Using human patient-derived organoids to identify genetic dependencies in pancreatic cancer Clinical Cancer Research. 22. DOI: 10.1158/1557-3265.Pdx16-B16  0.74
2016 Tiriac H, Ponz-Sarvise M, Corbo V, Frese KK, Engle DD, Ohlund D, Oni T, Hwang C, Handly-Santana A, Alagesan B, Filippini D, Wright K, Yu KH, Park Y, Tuveson DA. Abstract B64: Using pancreatic organoids to infer therapeutic resistance and sensitivity Cancer Research. 76. DOI: 10.1158/1538-7445.Panca16-B64  0.527
2016 Engle D, Tiriac H, Keith R, Ludwig M, Hwang C, Yu K, Pappin D, Tuveson D. Abstract A04: Identification of novel pancreatic cancer-specific biomarkers with organoid models Cancer Research. 76. DOI: 10.1158/1538-7445.Panca16-A04  0.635
2016 Hwang C, Lee E, Silva BD, Wright K, Park Y, Tuveson DA. Abstract 1027: Development of orthotopically grafted organoid models to study pancreatic cancer progression Cancer Research. 76: 1027-1027. DOI: 10.1158/1538-7445.Am2017-1027  0.617
2015 Hwang CI, Boj SF, Clevers H, Tuveson DA. Pre-clinical Models of Pancreatic Ductal Adenocarcinoma. The Journal of Pathology. PMID 26419819 DOI: 10.1002/Path.4651  0.631
2015 Boj SF, Hwang CI, Baker LA, Chio II, Engle DD, Corbo V, Jager M, Ponz-Sarvise M, Tiriac H, Spector MS, Gracanin A, Oni T, Yu KH, van Boxtel R, Huch M, et al. Organoid models of human and mouse ductal pancreatic cancer. Cell. 160: 324-38. PMID 25557080 DOI: 10.1016/J.Cell.2014.12.021  0.735
2014 Cheng CY, Hwang CI, Corney DC, Flesken-Nikitin A, Jiang L, Oner GM, Munroe RJ, Schimenti JC, Hermeking H, Nikitin AY. miR-34 cooperates with p53 in suppression of prostate cancer by joint regulation of stem cell compartment. Cell Reports. 6: 1000-7. PMID 24630988 DOI: 10.1016/J.Celrep.2014.02.023  0.32
2014 Ponz-Sarvise M, Corbo V, Öhlund D, Oni T, Handly-Santana A, Engle D, Tiriac H, Chio C, Feigin M, Baker L, Ardito-Abraham C, Park Y, Hwang C, Elyada E, Yu K, et al. 194 Pancreatic ductal organoids as a new platform for drug discovery European Journal of Cancer. 50: 63. DOI: 10.1016/S0959-8049(14)70320-X  0.532
2013 Flesken-Nikitin A, Hwang CI, Cheng CY, Michurina TV, Enikolopov G, Nikitin AY. Ovarian surface epithelium at the junction area contains a cancer-prone stem cell niche. Nature. 495: 241-5. PMID 23467088 DOI: 10.1038/Nature11979  0.395
2011 Hwang CI, Choi J, Zhou Z, Flesken-Nikitin A, Tarakhovsky A, Nikitin AY. MET-dependent cancer invasion may be preprogrammed by early alterations of p53-regulated feedforward loop and triggered by stromal cell-derived HGF. Cell Cycle (Georgetown, Tex.). 10: 3834-40. PMID 22071625 DOI: 10.4161/Cc.10.22.18294  0.413
2010 Choi J, Roy DM, Curtis SJ, Flesken-Nikitin A, Hwang C, Wang W, Nikitin AY. Abstract 4183: Modeling soft tissue sarcomas by conditional inactivation of p53 and Rb tumor suppressor genes Cancer Research. 70: 4183-4183. DOI: 10.1158/1538-7445.Am10-4183  0.434
2006 Lee MS, Jun DH, Hwang CI, Park SS, Kang JJ, Park HS, Kim J, Kim JH, Seo JS, Park WY. Selection of neural differentiation-specific genes by comparing profiles of random differentiation. Stem Cells (Dayton, Ohio). 24: 1946-55. PMID 16627687 DOI: 10.1634/Stemcells.2005-0325  0.3
2006 Kim SH, Hwang CI, Park WY, Lee JH, Song YS. GADD153 mediates celecoxib-induced apoptosis in cervical cancer cells. Carcinogenesis. 27: 1961-9. PMID 16597647 DOI: 10.1093/Carcin/Bgl027  0.367
2003 Seol JY, Park KH, Hwang CI, Park WY, Yoo CG, Kim YW, Han SK, Shim YS, Lee CT. Adenovirus-TRAIL can overcome TRAIL resistance and induce a bystander effect. Cancer Gene Therapy. 10: 540-8. PMID 12833134 DOI: 10.1038/Sj.Cgt.7700597  0.319
Show low-probability matches.